7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      ZBP1 governs the inflammasome-independent IL-1α and neutrophil inflammation that play a dual role in anti-influenza virus immunity

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Influenza A virus (IAV) triggers the infected lung to produce IL-1 and recruit neutrophils. Unlike IL-1β, however, little is known about IL-1α in terms of its mechanism of induction, action and physiological relevance to the host immunity against IAV infection. In particular, whether Z-DNA-binding protein 1 (ZBP1), a key molecule for IAV-induced cell death, is involved in the IL-1α induction, neutrophil infiltration and the physiological outcome has not been elucidated. Here, we show in a murine model that the IAV-induced IL-1α is mediated solely by ZBP1, in an NLRP3-inflammasome-independent manner, and is required for the optimal IL-1β production followed by the formation of neutrophil extracellular traps (NETs). During IAV infection, ZBP1 displays a dual role in anti-IAV immune responses mediated by neutrophils, resulting in either protective or pathological outcomes in vivo. Thus, ZBP1-mediated IL-1α production is the key initial step of IAV-infected NETs, regulating the duality of the consequent lung inflammation.

          Abstract

          ZBP1 and IL-1 control lung inflammation in influenza

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.

          The IL-1 family cytokines are regulated on transcriptional and posttranscriptional levels. Pattern recognition and cytokine receptors control pro-IL-1beta transcription whereas inflammasomes regulate the proteolytic processing of pro-IL-1beta. The NLRP3 inflammasome, however, assembles in response to extracellular ATP, pore-forming toxins, or crystals only in the presence of proinflammatory stimuli. How the activation of gene transcription by signaling receptors enables NLRP3 activation remains elusive and controversial. In this study, we show that cell priming through multiple signaling receptors induces NLRP3 expression, which we identified to be a critical checkpoint for NLRP3 activation. Signals provided by NF-kappaB activators are necessary but not sufficient for NLRP3 activation, and a second stimulus such as ATP or crystal-induced damage is required for NLRP3 activation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones

            Neutrophils play an important role in innate immunity by defending the host organism against invading microorganisms. Antimicrobial activity of neutrophils is mediated by release of antimicrobial peptides, phagocytosis as well as formation of neutrophil extracellular traps (NET). These structures are composed of DNA, histones and granular proteins such as neutrophil elastase and myeloperoxidase. This study focused on the influence of NET on the host cell functions, particularly on human alveolar epithelial cells as the major cells responsible for gas exchange in the lung. Upon direct interaction with epithelial and endothelial cells, NET induced cytotoxic effects in a dose-dependent manner, and digestion of DNA in NET did not change NET-mediated cytotoxicity. Pre-incubation of NET with antibodies against histones, with polysialic acid or with myeloperoxidase inhibitor but not with elastase inhibitor reduced NET-mediated cytotoxicity, suggesting that histones and myeloperoxidase are responsible for NET-mediated cytotoxicity. Although activated protein C (APC) did decrease the histone-induced cytotoxicity in a purified system, it did not change NET-induced cytotoxicity, indicating that histone-dependent cytotoxicity of NET is protected against APC degradation. Moreover, in LPS-induced acute lung injury mouse model, NET formation was documented in the lung tissue as well as in the bronchoalveolar lavage fluid. These data reveal the important role of protein components in NET, particularly histones, which may lead to host cell cytotoxicity and may be involved in lung tissue destruction.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis

              Complications of acute respiratory distress syndrome (ARDS) are common among critically ill patients infected with highly pathogenic influenza viruses. Macrophages and neutrophils constitute the majority of cells recruited into infected lungs, and are associated with immunopathology in influenza pneumonia. We examined pathological manifestations in models of macrophage- or neutrophil-depleted mice challenged with sublethal doses of influenza A virus H1N1 strain PR8. Infected mice depleted of macrophages displayed excessive neutrophilic infiltration, alveolar damage, and increased viral load, later progressing into ARDS-like pathological signs with diffuse alveolar damage, pulmonary edema, hemorrhage, and hypoxemia. In contrast, neutrophil-depleted animals showed mild pathology in lungs. The brochoalveolar lavage fluid of infected macrophage-depleted mice exhibited elevated protein content, T1-α, thrombomodulin, matrix metalloproteinase-9, and myeloperoxidase activities indicating augmented alveolar-capillary damage, compared to neutrophil-depleted animals. We provide evidence for the formation of neutrophil extracellular traps (NETs), entangled with alveoli in areas of tissue injury, suggesting their potential link with lung damage. When co-incubated with infected alveolar epithelial cells in vitro, neutrophils from infected lungs strongly induced NETs generation, and augmented endothelial damage. NETs induction was abrogated by anti-myeloperoxidase antibody and an inhibitor of superoxide dismutase, thus implying that NETs generation is induced by redox enzymes in influenza pneumonia. These findings support the pathogenic effects of excessive neutrophils in acute lung injury of influenza pneumonia by instigating alveolar-capillary damage.
                Bookmark

                Author and article information

                Journal
                Int Immunol
                Int Immunol
                intimm
                International Immunology
                Oxford University Press (UK )
                0953-8178
                1460-2377
                March 2020
                20 October 2019
                20 October 2019
                : 32
                : 3
                : 203-212
                Affiliations
                [1 ] Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research Center (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) , Osaka, Japan
                [2 ] Laboratory of Mockup Vaccine, Center for Vaccine and Adjuvant Research Center (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) , Osaka, Japan
                [3 ] Laboratory of Vaccine Science, World Premier International Immunology Frontier Research Center, Osaka University , Osaka, Japan
                [4 ] Malaria Immunology, World Premier International Immunology Frontier Research Center, Osaka University , Osaka, Japan
                [5 ] Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan
                [6 ] International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan
                [7 ] Department of Immunology, Hyogo College of Medicine , Hyogo, Japan
                [8 ] Laboratory of Regulation of Intractable Infectious Diseases, Center for Vaccine and Adjuvant Research Center (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) , Osaka, Japan
                [9 ] Host Defense, World Premier International Immunology Frontier Research Center, Osaka University , Osaka, Japan
                [10 ] Division of Malaria Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan
                Author notes
                Correspondence to: K. J. Ishii; E-mail: kenishii@ 123456ims.u-tokyo.ac.jp
                Author information
                https://orcid.org/0000-0002-7198-2190
                http://orcid.org/0000-0002-4467-7799
                http://orcid.org/0000-0002-6728-3872
                Article
                dxz070
                10.1093/intimm/dxz070
                10689344
                31630209
                d73d421d-f065-49d0-8edf-05d7d92df895
                © The Author(s) 2019. Published by Oxford University Press on behalf of The Japanese Society for Immunology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 04 September 2019
                : 17 October 2019
                : 14 October 2019
                : 24 November 2019
                Page count
                Pages: 10
                Funding
                Funded by: National Institutes of Biomedical Innovation, Health and Nutrition;
                Funded by: Japan Science and Technology Agency, DOI 10.13039/501100002241;
                Award ID: JPMJCR18H1
                Funded by: Japan Agency for Medical Research and Development, DOI 10.13039/100009619;
                Award ID: JP17ak0101068
                Award ID: JP18ak0101068
                Award ID: 17fm0208021h0001
                Categories
                Short Communications
                AcademicSubjects/MED00730

                Immunology
                il-1,influenza virus,innate immunity,neutrophil,zbp1
                Immunology
                il-1, influenza virus, innate immunity, neutrophil, zbp1

                Comments

                Comment on this article